IL2 and graft versus host disease: Supporting this, one study demonstrated a binary system where Tregs expressing a mutant oIL2Rβ were adoptively transferred into mice with graft-versus-host disease (GVHD) and treated with an orthogonal IL2 (oIL2) cytokine designed to bind exclusively to the engineered receptor.